NCT00665912

Platelet-Rich and Concentrated Platelet-Poor Plasma to Reduce Air Leak Post-Lobectomy: A Randomized Controlled Trial

Platelet-Rich and Concentrated Platelet Poor Plasma to Reduce Air Leak Post Lobectomy: A Randomized Controlled Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 204 (actual)
• Sponsor: Zimmer Biomet · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether the use of platelet-rich plasma (PRP) and concentrated platelet-poor plasma (PPPc) can reduce the duration of post-operative air leak after lobectomy for lung tumours.

Conditions

• Lung Cancer

Interventions

Type	Name	Description
PROCEDURE	Standard post-lobectomy wound care plus use of PRP and PPPc prepared by GPS and Plasmax respectively	GPS is used to create the platelet rich plasma (PRP). Plasmax is used to create the concentrated platelet-poor plasma (PPPc). Both PRP and PPPc will be used for wound care in the thoracic cavity post-lobectomy.
PROCEDURE	Standard post-lobectomy wound care	Standard post-lobectomy wound care

Timeline

• Start date: 2008-01-01
• Primary completion: 2010-05-01
• Completion: 2010-11-01
• First posted: 2008-04-24
• Last updated: 2017-03-13

Locations

1 site across 1 country: Canada